The 88 rating InvestorsObserver gives to Akebia Therapeutics Inc (AKBA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 100 percent of stocks in the Biotechnology industry, AKBA’s 88 overall rating means the stock scores better than 88 percent of all stocks.
AKBA has an Overall Score of 88. Find out what this means to you and get the rest of the rankings on AKBA!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 88 would rank higher than 88 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Akebia Therapeutics Inc Stock Today?
Akebia Therapeutics Inc (AKBA) stock is higher by 1.54% while the S&P 500 is lower by -0.35% as of 10:21 AM on Tuesday, Sep 12. AKBA has gained $0.02 from the previous closing price of $1.30 on volume of 0 shares. Over the past year the S&P 500 has gained 8.79% while AKBA has gained 214.29%. AKBA lost -$0.53 per share the over the last 12 months.
Click Here to get the full Stock Report for Akebia Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
